146 related articles for article (PubMed ID: 9452142)
1. Effects of protein tyrosine phosphatase inhibitors on EGF- and insulin-dependent mammary epithelial cell growth.
McIntyre BS; Briski KP; Hosick HL; Sylvester PW
Proc Soc Exp Biol Med; 1998 Feb; 217(2):180-7. PubMed ID: 9452142
[TBL] [Abstract][Full Text] [Related]
2. Role of protein kinase C in modulating epidermal growth factor- and phorbol ester-induced mammary epithelial cell growth in vitro.
Birkenfeld HP; McInntyre BS; Briski KP; Sylvester PW
Exp Cell Res; 1996 Feb; 223(1):183-91. PubMed ID: 8635491
[TBL] [Abstract][Full Text] [Related]
3. Protein tyrosine phosphorylation induced by epidermal growth factor and insulin-like growth factor-I in a rat clonal dental pulp-cell line.
Kawase T; Orikasa M; Ogata S; Burns DM
Arch Oral Biol; 1995 Oct; 40(10):921-9. PubMed ID: 8526802
[TBL] [Abstract][Full Text] [Related]
4. Genistein and erbstatin inhibition of normal mammary epithelial cell proliferation is associated with EGF-receptor down-regulation.
McIntyre BS; Sylvester PW
Cell Prolif; 1998 Feb; 31(1):35-46. PubMed ID: 9666817
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E inhibition of normal mammary epithelial cell growth is associated with a reduction in protein kinase C(alpha) activation.
Sylvester PW; McIntyre BS; Gapor A; Briski KP
Cell Prolif; 2001 Dec; 34(6):347-57. PubMed ID: 11736999
[TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine kinase inhibitors block the stimulatory actions of phosphotyrosine phosphatase inhibitors to increase cell proliferation, alkaline phosphatase activity, and collagen synthesis in normal human bone cells.
Yoon HK; Baylink DJ; Lau KH
Am J Nephrol; 2000; 20(2):153-62. PubMed ID: 10773618
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid modulation of epidermal growth factor-induced mouse mammary epithelial cell proliferation in vitro.
Sylvester PW; Birkenfeld HP; Hosick HL; Briski KP
Exp Cell Res; 1994 Sep; 214(1):145-53. PubMed ID: 8082717
[TBL] [Abstract][Full Text] [Related]
8. Role of GTP-binding proteins in reversing the antiproliferative effects of tocotrienols in preneoplastic mammary epithelial cells.
Sylvester PW; Nachnani A; Shah S; Briski KP
Asia Pac J Clin Nutr; 2002; 11 Suppl 7():S452-9. PubMed ID: 12492634
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix selectively modulates the response of mammary epithelial cells to different soluble signaling ligands.
Lee YJ; Streuli CH
J Biol Chem; 1999 Aug; 274(32):22401-8. PubMed ID: 10428812
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphatase inhibitors, vanadate and pervanadate, stimulate glucose transport and GLUT translocation in muscle cells by a mechanism independent of phosphatidylinositol 3-kinase and protein kinase C.
Tsiani E; Bogdanovic E; Sorisky A; Nagy L; Fantus IG
Diabetes; 1998 Nov; 47(11):1676-86. PubMed ID: 9792535
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
Gründker C; Völker P; Emons G
Endocrinology; 2001 Jun; 142(6):2369-80. PubMed ID: 11356684
[TBL] [Abstract][Full Text] [Related]
12. The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells.
Horsch K; Schaller MD; Hynes NE
Mol Endocrinol; 2001 Dec; 15(12):2182-96. PubMed ID: 11731619
[TBL] [Abstract][Full Text] [Related]
13. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
[TBL] [Abstract][Full Text] [Related]
14. Effects of mitogens on androgen receptor-mediated transactivation.
Reinikainen P; Palvimo JJ; Jänne OA
Endocrinology; 1996 Oct; 137(10):4351-7. PubMed ID: 8828495
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of mammary epithelial cell growth in vitro: interaction of epidermal growth factor and mammogenic hormones.
Imagawa W; Tomooka Y; Hamamoto S; Nandi S
Endocrinology; 1985 Apr; 116(4):1514-24. PubMed ID: 3882412
[TBL] [Abstract][Full Text] [Related]
16. Modulation of cyclin D1 and its signaling components by the phorbol ester TPA and the tyrosine phosphatase inhibitor vanadate.
Yan S; Wenner CE
J Cell Physiol; 2001 Mar; 186(3):338-49. PubMed ID: 11169972
[TBL] [Abstract][Full Text] [Related]
17. Relationship between epidermal growth factor receptor levels, autophosphorylation and mitogenic-responsiveness in normal mouse mammary epithelial cells in vitro.
McIntyre BS; Birkenfeld HP; Sylvester PW
Cell Prolif; 1995 Jan; 28(1):45-56. PubMed ID: 7833385
[TBL] [Abstract][Full Text] [Related]
18. Protein-tyrosine phosphatase-mediated decrease of epidermal growth factor and platelet-derived growth factor receptor tyrosine phosphorylation in high cell density cultures.
Sörby M; Ostman A
J Biol Chem; 1996 May; 271(18):10963-6. PubMed ID: 8631915
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of a Src homology 2 domain containing protein tyrosine phosphatase by vanadate in the primary culture of hepatocytes.
Pugazhenthi S; Tanha F; Dahl B; Khandelwal RL
Arch Biochem Biophys; 1996 Nov; 335(2):273-82. PubMed ID: 8914924
[TBL] [Abstract][Full Text] [Related]
20. Possible regulation of epidermal growth factor-receptor tyrosine autophosphorylation by calcium and G proteins in chemically permeabilized rat UMR106 cells.
Kawase T; Orikasa M; Oguro A; Burns DM
Arch Oral Biol; 1999 Feb; 44(2):157-71. PubMed ID: 10206334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
